share_log

Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff

Benzinga ·  Apr 16 11:49

$Johnson & Johnson (JNJ.US)$delivered a rather mixed first-quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost in line with estimates. First quarter results came shortly after JNJ's expansion in the cardiovascular space with the $13.1 billion acquisition of the heart device firm$ShockWave Medical (SWAV.US)$.

First Quarter Highlights

For the period ended in March, the healthcare company posted a revenue of $21.38 billion, almost in line with LSEG's estimate of $21.4 billion. During the first three months of the year, revenue rose more than 2% YoY. JNJ reported a net income of $5.35 billion, or $2.20 per share...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment